Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;41(2):110-122.
doi: 10.1016/j.tips.2019.11.005. Epub 2019 Dec 18.

Insight into the Structural Features of TSPO: Implications for Drug Development

Affiliations
Review

Insight into the Structural Features of TSPO: Implications for Drug Development

Jean-Jacques Lacapere et al. Trends Pharmacol Sci. 2020 Feb.

Abstract

The translocator protein (TSPO), an 18-kDa transmembrane protein primarily found in the outer mitochondrial membrane, is evolutionarily conserved and widely distributed across species. In mammals, TSPO has been described as a key member of a multiprotein complex involved in many putative functions and, over the years, several classes of ligand have been developed to modulate these functions. In this review, we consider the currently available atomic structures of mouse and bacterial TSPO and propose a rationale for the development of new ligands for the protein. We provide a review of TSPO monomeric and oligomeric states and their conformational flexibility, together with ligand-binding site and interaction mechanisms. These data are expected to help considerably the development of high-affinity ligands for TSPO-based therapies or diagnostics.

Keywords: X-ray crystallography; nuclear magnetic resonance; positron emission tomography; protein flexibility; protein ligand interactions.

PubMed Disclaimer

Conflict of interest statement

DISCLAIMER STATEMENT

The authors declare no conflict of interest

Figures

Figure 1.
Figure 1.. Overlap of molecules in the cavity of TSPO.
(A) Scheme of PPIX ligand structure. (B) PPIX (carbons in green, oxygens in red) in RsTSPO (PDB entry 4UC1). (C) PK 11195 (carbons in magenta, hydrogens in white, nitrogens in blue, chlorine in green) in BcTSPO (PDB entry 4RYI). (D) PK 11195 (carbons in magenta, nitrogens in blue, chlorine in green) in mTSPO (PDB entry 2MGY). (E) Water (doted red spheres) in BcTSPO (PDB entry 4RYQ). Dark red spheres correspond to water molecules in the selected slice whereas shadowed red spheres correspond to water molecules located underneath. (F) Water (doted red spheres) in RsTSPO (PDB entry 4UC1). (G) DMSO (carbons in red, hydrogens in white and sulfur in yellow) in BcTSPO (PDB entry 4RYO). (H) Iodine (magenta spheres) in BcTSPO (PDB entry 4RYM) In each case, the TSPO atomic structure is shown as rainbow cartoon colored as follows: TM1, blue; TM2, green; TM3, light green; TM4, yellow; TM5, red using PyMol (https://pymol.org/2/) [93].
Box 1, Figure I.
Box 1, Figure I.. Interaction of PK 11195 with mTSPO and BcTSPO
(A) Structure of (R) PK 11195 ligand. Φ1, Φ2, Φ3 and Φ4 are the respective dihedral angles for CH3-N-C=O, CH3-CH-N-CH3, N-CH-C=O and chlorophenyl-isoquinoline ring, respectively. Red cross shows the asymmetric carbon and the red arrows show the rotation of the bond corresponding to the various Φ angles. (B) Overlay of aligned (R) PK 11195 bound in the binding cavity of mTSPO (yellow) and BcTSPO (red) (PDB ID-2MGY and 4RYI respectively). The isoquinoline plane is shown as dotted parallelogram. (C) and (D) General structures of ER 176 and Nebiquinide, respectively. Red circles emphasize the chemical substitutions introduced compared to PK 11195 (A).

References

    1. Papadopoulos V et al. (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci 27(8), 402–409. - PubMed
    1. Fan J et al. (2012) Structural and functional evolution of the translocator protein (18kDa) Curr. Mol. Med 12, 36–386. - PubMed
    1. Guilarte TR (2019) TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward. Pharm. Therap 194, 44–58. - PMC - PubMed
    1. Narayanaswami V et al. (2018) Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO. Mol. Imag 17, 1–25. - PMC - PubMed
    1. Largeau B et al. (2017) TSPO PET imaging: from microglial activation to peripheral sterile inflammation diseases? Contrast Media Mol. Imaging 6592139. - PMC - PubMed

Publication types